Pub. date: 2008 | Online Pub. Date: May 22, 2008 | DOI: 10.4135/9781848605985 | Print ISBN: 9781847870483 | Online ISBN: 9781848605985 | Publisher:SAGE Publications LtdAbout this handbook
Chapter 15: Opportunities and Challenges in the Japanese Market for Cancer Therapies
Opportunities and challenges in the japanese market for cancer therapies Since 1981, cancer has been the leading cause of death in Japan, and cancer mortality in that country has grown rapidly. Table 15.1 shows that the number of recorded deaths from cancers in Japan increased from 217,413 in 1990 to 320,358 in 2004, an increase of 47.3% in 14 years. In 2004, the death rate per 100,000 of population was 253.9, equivalent to 31.1% of the total number of deaths. According to the Ministry of Health, Labor, and Welfare (MHLW), cancers of the respiratory system (i.e., trachea, bronchus, lungs) were the most common causes of cancer-related mortality, followed by stomach and colorectal cancer. The aging of the Japanese population is expected to contribute to a continued increase in cancer mortality. Table 15.2 shows that the number of people aged 65 and older increased from 10.7 million (9.1% of the Given ...